Today we decided to take a look at the price of Ozempic.

Today we decided to take a look at the price of Ozempic.

The current Ozempic shortage has been driven by the increase in demand as the drug is being used to treat obese patients for long term weight management, in addition to the original group of type 2 diabetes patients. A study run by the University College London (UCL),...
Are concessions and shortages caused by the DHSC?

Are concessions and shortages caused by the DHSC?

It would seem sensible to assume that profitable products are less likely to suffer shortages, concessions and price spikes than products where profit is hard to come by. Charles Joynson, WaveData MD, compared the reimbursement price and the average market price for...
What’s the future for my brand post loss of exclusivity (LOE)?

What’s the future for my brand post loss of exclusivity (LOE)?

Charles Joynson, WaveData MD, puts a spotlight on Lustral Tabs as we explore the product lifecycle post LOE. Before generics were launched in November 2005 there was a high degree of similarity between the price of the UK and PI (parallel import) packs of Lustral Tabs...
Is the VPAS Scheme doing more harm than good? Part Two…….

Is the VPAS Scheme doing more harm than good? Part Two…….

VPAS continues to be one of the top priorities for the UK Pharma Industry. A week or so ago, we undertook some analysis on Originator Brands, assessing profitability and UK market attractiveness. If the rebate is unsustainable, and results in loss making products for...